Erudio Healtherudio.com
Sponsor
M.D. Anderson Cancer Center trials: what clinicians said in public
An HCP commentary report on 1 clinical trial sponsored by M.D. Anderson Cancer Center: EXTEND-OP. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 34 more trials with public commentary and no report yet.
Listed by lead sponsor as registered on ClinicalTrials.gov (M.D. Anderson Cancer Center). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| EXTEND-OP NCT06367972 · M.D. Anderson Cancer Center | oligoprogressive metastatic disease | Phase 2/Phase 3 | 25 | 3 | Focused | Nov 1, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| NCT00352846 NCT00352846 · M.D. Anderson Cancer Center DeepView → | chemotherapy-induced bone loss in non-Hodgkin lymphoma | Phase 3 | Deep | View | |||
| LONESTAR NCT03391869 · M.D. Anderson Cancer Center DeepView → | stage IV non-small cell lung cancer | Phase 3 | Deep | View | |||
| OLIGOMEZ NCT01725165 · M.D. Anderson Cancer Center DeepView → | oligometastatic non-small cell lung cancer | Phase 2 | Deep | View | |||
| SAPHIRE NCT02912312 · M.D. Anderson Cancer Center StandardView → | invasive breast cancer | Phase 2 | Standard | View | |||
| DETERRED NCT02525757 · M.D. Anderson Cancer Center StandardView → | unresectable non-small cell lung cancer | Phase 2 | Standard | View | |||
| BOOST-RCC NCT06284564 · M.D. Anderson Cancer Center StandardView → | metastatic renal cell carcinoma | Phase 2 | Standard | View | |||
| C3NIRA NCT04592237 · M.D. Anderson Cancer Center FocusedView → | aggressive variant metastatic prostate cancer | Phase 2 | Focused | View | |||
| NCT03575611 NCT03575611 · M.D. Anderson Cancer Center FocusedView → | oligometastatic clear-cell renal cell carcinoma | Phase 2 | Focused | View | |||
| IMPACT2 NCT02152254 · M.D. Anderson Cancer Center FocusedView → | metastatic cancer | Phase 2 | Focused | View | |||
| NORTHSTAR NCT03410043 · M.D. Anderson Cancer Center FocusedView → | EGFR-mutant metastatic NSCLC | Phase 2 | Focused | View | |||
| REPLOT NCT06408168 · M.D. Anderson Cancer Center FocusedView → | Not given | Phase 2 | Focused | View | |||
| ENPAC NCT02684227 · M.D. Anderson Cancer Center FocusedView → | advanced or recurrent endometrioid endometrial cancer | Phase 2 | Focused | View | |||
| NCT02812420 NCT02812420 · M.D. Anderson Cancer Center FocusedView → | Not given | Early phase 1 | Focused | View | |||
| NCT06940518 NCT06940518 · M.D. Anderson Cancer Center FocusedView → | Not given | Phase 2 | Focused | View | |||
| NCT01751438 NCT01751438 · M.D. Anderson Cancer Center FocusedView → | Not given | Phase 2 | Focused | View | |||
| NCT02945579 NCT02945579 · M.D. Anderson Cancer Center FocusedView → | stage I–II HER2-positive or triple-negative breast cancer | Not applicable | Focused | View | |||
| NCT02115295 NCT02115295 · M.D. Anderson Cancer Center FocusedView → | acute myeloid leukemia or high-risk myelodysplastic syndrome | Phase 2 | Focused | View | |||
| NCT02357992 NCT02357992 · M.D. Anderson Cancer Center FocusedView → | Not given | Not applicable | Focused | View | |||
| NCT05012371 NCT05012371 · M.D. Anderson Cancer Center FocusedView → | metastatic clear cell renal cell carcinoma | Phase 2 | Focused | View | |||
| NCT06284486 NCT06284486 · M.D. Anderson Cancer Center FocusedView → | acute myeloid leukemia with MRD | Phase 1/Phase 2 | Focused | View | |||
| BrightStar-2 NCT06522360 · M.D. Anderson Cancer Center FocusedView → | ALK-positive advanced non-small cell lung cancer | Phase 2 | Focused | View | |||
| NCT01787487 NCT01787487 · M.D. Anderson Cancer Center FocusedView → | myelofibrosis or myelodysplastic syndrome/myeloproliferative neoplasms | Phase 2 | Focused | View | |||
| NCT02420717 NCT02420717 · M.D. Anderson Cancer Center FocusedView → | Not given | Phase 2 | Focused | View | |||
| NCT02703623 NCT02703623 · M.D. Anderson Cancer Center FocusedView → | metastatic castration-resistant prostate cancer | Phase 2 | Focused | View | |||
| NCT02846623 NCT02846623 · M.D. Anderson Cancer Center FocusedView → | chronic lymphocytic leukemia, small lymphocytic lymphoma, Richter syndrome | Phase 2 | Focused | View | |||
| I-SABR NCT03110978 · M.D. Anderson Cancer Center FocusedView → | Not given | Phase 2 | Focused | View | |||
| MR-ADAPTOR NCT03224000 · M.D. Anderson Cancer Center FocusedView → | HPV+ oropharyngeal squamous cell carcinoma | Phase 2 | Focused | View | |||
| NCT03469284 NCT03469284 · M.D. Anderson Cancer Center FocusedView → | intractable pain from oral mucositis | Phase 2 | Focused | View | |||
| NCT03471260 NCT03471260 · M.D. Anderson Cancer Center FocusedView → | Not given | Phase 1/Phase 2 | Focused | View | |||
| CABOSUN II NCT03541902 · M.D. Anderson Cancer Center FocusedView → | Not given | Phase 2 | Focused | View | |||
| NCT03599765 NCT03599765 · M.D. Anderson Cancer Center FocusedView → | Not given | Phase 2 | Focused | View | |||
| NCT04140487 NCT04140487 · M.D. Anderson Cancer Center FocusedView → | newly diagnosed or relapsed/refractory FLT3-mutated acute myeloid leukemia | Phase 1/Phase 2 | Focused | View | |||
| NCT04479306 NCT04479306 · M.D. Anderson Cancer Center FocusedView → | osimertinib-resistant EGFR-mutant stage IIIB/IV non-small cell lung cancer | Phase 1 | Focused | View | |||
| STOPTRAFFIC-1 NCT04599140 · M.D. Anderson Cancer Center FocusedView → | refractory RAS-mutated microsatellite stable metastatic colorectal cancer | Phase 1/Phase 2 | Focused | View | |||